Skip Navigation


Journal of Intellectual Property Law & Practice Advance Access originally published online on February 7, 2006
Journal of Intellectual Property Law & Practice 2006 1(4):235-237; doi:10.1093/jiplp/jpl009
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1/4/235    most recent
jpl009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Wright, G.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press. All rights reserved.

Current Intelligence

Supplementary protection certificates: Advocate General's opinion on formulations

Gordon Wright, Dr
Partner, Elkington and Fife LLP London, UK

The opinion of Advocate General Léger, published on 24 November 2005 in C-431/04, opens the way for extending the duration of certain pharmaceutical formulation patents by means of a supplementary protection certificate (SPC).


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.